Your browser doesn't support javascript.
loading
Proteomic characterization of epithelial ovarian cancer delineates molecular signatures and therapeutic targets in distinct histological subtypes.
Gong, Ting-Ting; Guo, Shuang; Liu, Fang-Hua; Huo, Yun-Long; Zhang, Meng; Yan, Shi; Zhou, Han-Xiao; Pan, Xu; Wang, Xin-Yue; Xu, He-Li; Kang, Ye; Li, Yi-Zi; Qin, Xue; Xiao, Qian; Huang, Dong-Hui; Li, Xiao-Ying; Zhao, Yue-Yang; Zhao, Xin-Xin; Wang, Ya-Li; Ma, Xiao-Xin; Gao, Song; Zhao, Yu-Hong; Ning, Shang-Wei; Wu, Qi-Jun.
Afiliação
  • Gong TT; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Guo S; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  • Liu FH; Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Huo YL; Clinical Research Center, Shengjing Hospital of China Medical University, Shenyang, China.
  • Zhang M; Key Laboratory of Precision Medical Research on Major Chronic Disease, Shengjing Hospital of China Medical University, Shenyang, China.
  • Yan S; Department of Pathology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Zhou HX; Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Pan X; Clinical Research Center, Shengjing Hospital of China Medical University, Shenyang, China.
  • Wang XY; Key Laboratory of Precision Medical Research on Major Chronic Disease, Shengjing Hospital of China Medical University, Shenyang, China.
  • Xu HL; Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Kang Y; Clinical Research Center, Shengjing Hospital of China Medical University, Shenyang, China.
  • Li YZ; Key Laboratory of Precision Medical Research on Major Chronic Disease, Shengjing Hospital of China Medical University, Shenyang, China.
  • Qin X; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  • Xiao Q; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  • Huang DH; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  • Li XY; Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Zhao YY; Clinical Research Center, Shengjing Hospital of China Medical University, Shenyang, China.
  • Zhao XX; Key Laboratory of Precision Medical Research on Major Chronic Disease, Shengjing Hospital of China Medical University, Shenyang, China.
  • Wang YL; Department of Pathology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Ma XX; Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Gao S; Clinical Research Center, Shengjing Hospital of China Medical University, Shenyang, China.
  • Zhao YH; Key Laboratory of Precision Medical Research on Major Chronic Disease, Shengjing Hospital of China Medical University, Shenyang, China.
  • Ning SW; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Wu QJ; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
Nat Commun ; 14(1): 7802, 2023 Nov 28.
Article em En | MEDLINE | ID: mdl-38016970
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Carcinoma Endometrioide Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Carcinoma Endometrioide Idioma: En Ano de publicação: 2023 Tipo de documento: Article